Nasdaq · Healthcare
Strata Critical Medical, Inc. (SRTA)
As-reported financials and recent SEC filings for Strata Critical Medical, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$197.1M
Net income
$41.3M
Net margin
21.0%
Diluted EPS
$0.50
ROE
14.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | $50.5M |
| Gross profit | $41.1M | $29.6M | $42.1M | $22.3M | $10.5M |
| Operating income | $-22.4M | $-22.5M | $-68.1M | $-53.5M | $-24.1M |
| Net income | $41.3M | $-27.3M | $-56.1M | $-27.3M | $-40.1M |
| Diluted EPS | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
4/A2026-06-18
View on EDGAR →4/A2026-06-18
View on EDGAR →4/A2026-06-18
View on EDGAR →4/A2026-06-18
View on EDGAR →SCHEDULE 13G2026-06-17
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →Largest Healthcare peers
Go deeper on SRTA
Search Strata Critical Medical, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.